Proceedings of the Standing Senate Committee on
Social Affairs, Science and Technology
Issue 37 - Twenty-second Report of the Committee
Tuesday, April 23, 2013
The Standing Senate Committee on Social Affairs, Science and Technology has the honour to present its
TWENTY-SECOND REPORT
Your committee, which was authorized by the Senate on Tuesday, November 22, 2011 to examine and report on prescription pharmaceuticals in Canada, respectfully requests funds for the fiscal year ending March 31, 2014.
Pursuant to Chapter 3:06, section 2(1)(c) of the Senate Administrative Rules, the budget submitted to the Standing Committee on Internal Economy, Budgets and Administration and the report thereon of that committee are appended to this report.
Respectfully submitted,
KELVIN K. OGILVIE
Chair
STANDING COMMITTEE ON
SOCIAL AFFAIRS, SCIENCE AND TECHNOLOGY
SPECIAL STUDY ON PRESCRIPTION PHARMACEUTICALS IN CANADA
APPLICATION FOR BUDGET AUTHORIZATION
FOR THE FISCAL YEAR ENDING MARCH 31, 2014
Extract from the Journals of the Senate, Tuesday, November 22, 2011:
The Honourable Senator Ogilvie, pursuant to notice of November 17, 2011, moved:
That the Senate Standing Committee on Social Affairs, Science and Technology be authorized to examine and report on prescription pharmaceuticals in Canada, including but not limited to:
(a) the process to approve prescription pharmaceuticals with a particular focus on clinical trials;
(b) the post-approval monitoring of prescription pharmaceuticals;
(c) the off-label use of prescription pharmaceuticals; and
(d) the nature of unintended consequences in the use of prescription pharmaceuticals.
That the committee submit its final report no later than December 31, 2013, and that the committee retain until March 31, 2014, all powers necessary to publicize its findings.
The question being put on the motion, it was adopted.
Gary W. O'Brien
Clerk of the Senate
SUMMARY OF EXPENDITURES
| GENERAL EXPENSES | $30,600 |
| TOTAL | $30,600 |
The above budget was approved by the Standing Senate Committee on Social Affairs, Science and Technology on February 27, 2013.
The undersigned or an alternate will be in attendance on the date that this budget is considered.
| Date | Kelvin K. Ogilvie | |
| Chair, Standing Senate Committee on Social Affairs, Science and Technology |
| Date | David Tkachuk | |
| Chair, Standing Committee on Internal Economy, Budgets and Administration |
HISTORICAL INFORMATION
The committee was granted a budget of $55,200 for the 2012-1013 fiscal year for this study.
GENERAL ESTIMATE OF THE TOTAL COST OF THE SPECIAL STUDY
Pursuant to Chapter 3:06, section 2(2) of the Senate Administrative Rules, the total estimated cost for this study, including this budget, is $99,600. This estimate includes funds for the 2014-2015 fiscal year. An extension of the reporting deadline for this study will be requested at the appropriate time.
STANDING COMMITTEE ON
SOCIAL AFFAIRS, SCIENCE AND TECHNOLOGY
SPECIAL STUDY ON PRESCRIPTION PHARMACEUTICALS IN CANADA
APPLICATION FOR BUDGET AUTHORIZATION FOR THE FISCAL
YEAR ENDING MARCH 31, 2014
| GENERAL EXPENSES | ||||||||
| PROFESSIONAL AND OTHER SERVICES | ||||||||
| 1. | Communications consultant - graphic designer (0303) | 15,000 | ||||||
| 2. | Communications consultant - editing services (0303) | 11,100 | ||||||
| (150 hourss, $74/hours) | ||||||||
| Sub-total | $26,100 | |||||||
| ALL OTHER EXPENDITURES | ||||||||
| OTHER | ||||||||
| 1. | Miscellaneous expenses (0798) | 500 | ||||||
| PRINTING | ||||||||
| 2. | Printing (0321) | 4,000 | ||||||
| Sub-total | $4,500 | |||||||
| Total | $30,600 | |||||||
The Senate administration has reviewed this budget application.
| Heather Lank, Principal Clerk, Committees Directorate |
Date |
| Nicole Proulx, Director of Finance and Procurement | Date |
APPENDIX (B) TO THE REPORT
Thursday, April 18, 2013
The Standing Committee on Internal Economy, Budgets and Administration has examined the budget presented to it by the Standing Senate Committee on Social Affairs, Science and Technology for the proposed expenditures of the said Committee for the fiscal year ending March 31, 2014 for the purpose of its special study on prescription pharmaceuticals in Canada, as authorized by the Senate on Tuesday, November 22, 2011. The approved budget is as follows:
General Expenses $ 30,600 TOTAL $ 30,600
Respectfully submitted,
DAVID TKACHUK
Chair